Ranbaxy Recalls Generic Version Of Pfizer's Lipitor Over Glass Particles
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories issued a recall of some batches of its generic version of Pfizer's Lipitor (atorvastatin) from the U.S. market even as the India drug maker continues to comply with a consent decree to settle a long-term ban on Ranbaxy products.